SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-009171
Filing Date
2021-02-26
Accepted
2021-02-26 06:04:01
Documents
7
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 6-K orph-6k_20210226.htm 6-K 22161
2 EX-3.1 orph-ex31_7.htm EX-3.1 126093
3 EX-99.1 orph-ex991_6.htm EX-99.1 18396
4 GRAPHIC gfvmr3xitbdc000002.jpg GRAPHIC 5564
5 GRAPHIC gsaxjzvx1umx000001.jpg GRAPHIC 2775
6 GRAPHIC gsaxjzvx1umx000002.jpg GRAPHIC 5319
7 GRAPHIC gfvmr3xitbdc000001.jpg GRAPHIC 5596
  Complete submission text file 0001564590-21-009171.txt   194765
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Filer) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39545 | Film No.: 21683584
SIC: 2834 Pharmaceutical Preparations